Literature DB >> 16086906

Comparison of end normal inspiration and expiration for gated intensity modulated radiation therapy (IMRT) of lung cancer.

Cesar Della Biancia1, Ellen Yorke, Chen-Shou Chui, Philippe Giraud, Kenneth Rosenzweig, Howard Amols, Clifton Ling, Gig S Mageras.   

Abstract

BACKGROUND AND
PURPOSE: Gated delivery of radiation during part of the respiration cycle may improve the treatment of lung cancer with intensity modulated radiation therapy (IMRT). In terms of the respiration phase for gated treatment, normal end-expiration (EE) is more stable but normal end-inspiration (EI) increases lung volume. We compare the relative merit of using EI and EE in gated IMRT for sparing normal lung tissue. PATIENTS AND METHODS: Ten patients received EI and EE respiration-triggered CT scans in the treatment position. An IMRT plan for a prescription dose of 70 Gy was generated for each patient and at each respiration phase. The optimization constraints included target dose uniformity, less than 35% of the total lung receiving 20 Gy or more and maximum cord dose <or=45 Gy. We compared planning target volume (PTV) coverage, mean lung dose, percentage of total lung receiving 20 Gy or more (V(20)) and lung normal tissue complication probability (NTCP).
RESULTS: For 9 of the 10 patients, cord and lung doses were acceptable and PTV coverage was similar for EE and EI, with lung sparing was equal to or slightly better at EI than at EE. For the 10th patient, lung sparing at EI was significantly better. Patient averaged mean lung dose was 15.4 Gy (range: 7.1-20.4) at EI and 16.3 Gy (range: 6.9-21.9) at EE. The average V(20) was 23.8% (range: 13-36.4) at EI and 25.3% (range: 13-37.3) at EE. The average NTCP at EI was 8 versus 12% at EE.
CONCLUSIONS: Dosimetric indices of lung protection for IMRT plans at EI are better than at EE. For 9 out of the 10 patients in our study, this difference is small. Thus other factors such as reproducibility, reliability and duty cycle at normal end expiration may be more critical for selecting treatment breathing phase.

Entities:  

Mesh:

Year:  2005        PMID: 16086906     DOI: 10.1016/j.radonc.2005.01.008

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  12 in total

1.  A mass-conserving 4D XCAT phantom for dose calculation and accumulation.

Authors:  Christopher L Williams; Pankaj Mishra; Joao Seco; Sara St James; Raymond H Mak; Ross I Berbeco; John H Lewis
Journal:  Med Phys       Date:  2013-07       Impact factor: 4.071

2.  Preliminary clinical evaluation of a 4D-CBCT estimation technique using prior information and limited-angle projections.

Authors:  You Zhang; Fang-Fang Yin; Tinsu Pan; Irina Vergalasova; Lei Ren
Journal:  Radiother Oncol       Date:  2015-03-26       Impact factor: 6.280

3.  Feasibility of automated pancreas segmentation based on dynamic MRI.

Authors:  S Gou; J Wu; F Liu; P Lee; S Rapacchi; P Hu; K Sheng
Journal:  Br J Radiol       Date:  2014-10-01       Impact factor: 3.039

4.  A biomechanical modeling-guided simultaneous motion estimation and image reconstruction technique (SMEIR-Bio) for 4D-CBCT reconstruction.

Authors:  Xiaokun Huang; You Zhang; Jing Wang
Journal:  Phys Med Biol       Date:  2018-02-08       Impact factor: 3.609

5.  Quantitative analysis of the intra-beam respiratory motion with baseline drift for respiratory-gating lung stereotactic body radiation therapy.

Authors:  Kenji Yasue; Hiraku Fuse; Satoshi Oyama; Koichi Hanada; Kazuya Shinoda; Hideaki Ikoma; Tatsuya Fujisaki; Yoshio Tamaki
Journal:  J Radiat Res       Date:  2022-01-20       Impact factor: 2.724

6.  Intensity-modulated radiation therapy (IMRT) for inoperable non-small cell lung cancer: the Memorial Sloan-Kettering Cancer Center (MSKCC) experience.

Authors:  Sonal Sura; Vishal Gupta; Ellen Yorke; Andrew Jackson; Howard Amols; Kenneth E Rosenzweig
Journal:  Radiother Oncol       Date:  2008-03-17       Impact factor: 6.280

7.  An evaluation of planning techniques for stereotactic body radiation therapy in lung tumors.

Authors:  Jianzhou Wu; Huiling Li; Raj Shekhar; Mohan Suntharalingam; Warren D'Souza
Journal:  Radiother Oncol       Date:  2008-03-24       Impact factor: 6.280

8.  A study on the influence of breathing phases in intensity-modulated radiotherapy of lung tumours using four-dimensional CT.

Authors:  W C Wu; C L Chan; Y W Wong; J P Cuijpers
Journal:  Br J Radiol       Date:  2009-09-01       Impact factor: 3.039

9.  The effects of breath-holding on pulmonary regurgitation measured by cardiovascular magnetic resonance velocity mapping.

Authors:  Bengt Johansson; Sonya V Babu-Narayan; Philip J Kilner
Journal:  J Cardiovasc Magn Reson       Date:  2009-01-14       Impact factor: 5.364

10.  A method of respiratory phase optimization for better dose sparing of organs at risks: A validation study in patients with lung cancer.

Authors:  Seong-Hee Kang; Siyong Kim; Dong-Su Kim; Tae-Ho Kim; So-Hyun Park; Dong-Seok Shin; Kyeong-Hyeon Kim; Min-Seok Cho; YeonSil Kim; Tae Suk Suh
Journal:  Oncotarget       Date:  2017-12-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.